Alpha Tribe
FeedCompaniesAgentsSubscribe

Filter announcements

  • All
  • Important
  • Results
  • Board Meeting
  • New Orders
  • QIP/Rights/Pref.
  • PPTs
  • JV/Acquisition
  • Insider Trade
  • Dividend/Bonus
  • Credit Ratings
  • Updates
  • Pledging
  • Investor Meet
  • Others

Download our app

Best experience on mobile

Get it on Google PlayDownload on the App Store

Join 5K+ users on Alpha Tribe

Loading...
RPG Life Sciences Limited logo

RPG Life Sciences Limited

RPGLIFE·Pharmaceuticals

RPG Life Sciences Ltd is engaged in the manufacturing and marketing of Formulations (Finished Dosage Forms) and Active Pharmaceutical Ingredients (APIs) in the domestic and international market.The company is a part of RPG group which is a diversified conglomerate with interests in areas of infrastructure, tyres, information technology, pharmaceuticals, energy and plantations.The group is headed by Harsh Goenka.

177Announcements
09-09-2026Last filed
37Last 90 days

What RPG files

  • Others64
  • Updates30
  • Investor Meet25
  • Important25
  • Board Meeting15
  • PPTs10
Showing PPTs announcements (10)Clear filter
02-09-2026 · 10:34 pm

RPG Life Sciences has strategically spun off its Active Pharmaceutical Ingredients (API) business into a new subsidiary, RPG Active Pharma (RPGAP). This move aims for sharper focus and growth. The API unit recorded ~95.1 Cr in external sales in FY26, specializing in high-value niche products. In a key development, RPGAP...

Read the full announcement→
PDF
28-07-2026 · 08:38 pm

RPG Life Sciences reported a robust Q1 FY27, with revenue climbing 15.8% to ₹195.7 Cr and profit after tax (PAT) up 17.0% to ₹30.8 Cr, achieving a 15.7% PAT margin. Domestic Formulations (DF) led sales, growing 14.8% and contributing 68.3% of total revenue. International Formulations (IF) saw a 7.7% increase,...

Read the full announcement→
PDF
25-05-2026 · 08:53 pm

RPG Life Sciences delivered robust FY26 results, with revenue growing 8.3% YoY to ₹707.5 Cr. Domestic Formulations, contributing 69% of sales, was a key performer, growing 1.6x faster than the Indian Pharma Market and ranking as the 4th fastest-growing company in IPM during Q4. Strong profitability led to an EBITDA...

Read the full announcement→
PDF
30-04-2026 · 02:04 pm

Here is the financial summary for RPG Life Sciences: **Business Performance:** RPG Life Sciences delivered robust Q4 FY26, with revenue jumping 23.6% to 176.9 Cr and PAT (excluding exceptional items) soaring 58.1% to 29.3 Cr. For FY26, revenue grew 8.3% to 707.5 Cr. Domestic Formulations led performance, up 13.7% for...

Read the full announcement→
PDF
17-10-2025 · 06:08 pm

RPG Life Sciences reported H1 FY26 revenue of 350.6 Cr, up 3.8% year-over-year (YoY), with Q2 revenue growing 5.5% YoY to 181.7 Cr. However, profit after tax (PAT) saw a 6.0% YoY decline in H1 to 54.8 Cr and a 9.6% decline in Q2 to 28.5 Cr, indicating margin pressure....

Read the full announcement→
PDF